The Pharmacovigilance & Risk Management Strategies Conference is bringing experts and industry leaders together. This interactive and debate-driven meeting is a one-of-a-kind event, offering delegates the unique opportunity to network and benchmark with their peers in a roundtable format.
Benefits of attending:
Investigate the Current Regulations and Guidelines on USA and EU Pharmacovigilance.
Insight into Building Proactive Risk Management Strategies.
Introduce the New Guidelines on Adverse Event Reporting (AER) Requirements
VP, Therapeutic Area Head, Neuroscience & GI, Pharmacovigilance & Risk Management Shire
John Brownstein - Associate Professor - Harvard Medical School, Epidemiologist - Yale University
Mauricha Marcussen - Program Manager, Global Labeling, Advertising & Promotion (Regulatory Affairs)
Who should attend:
C-Level Executives, SVP’s, VP’s, Directors, and Chief Safety Officers from the
Best Pharmaceutical & Biotechnology Organizations who are Responsible for:
• Drug Safety
• Risk Management
• Drug & Product Safety
• Medical Directors
• Customer Engagement
• Regulatory Affairs
• Signal Detection
• Clinical Safety
• Patient & Medical Safety